Cargando…
Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.
The cell cycle regulatory proteins p16 and p21 cause cell cycle arrest at the G1 checkpoint by inhibiting activity of cyclin D-CDK4 complexes. The TP53 gene, regulating the p21 protein, is mutated at high frequency in ovarian cancer. The CDKN2 gene, encoding the p16 protein, has been mapped to chrom...
Autores principales: | Schuyer, M., van Staveren, I. L., Klijn, J. G., vd Burg, M. E., Stoter, G., Henzen-Logmans, S. C., Foekens, J. A., Berns, E. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077110/ https://www.ncbi.nlm.nih.gov/pubmed/8855976 |
Ejemplares similares
-
Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.
por: Berns, E. M., et al.
Publicado: (1995) -
Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.
por: Henzen-Logmans, S. C., et al.
Publicado: (1992) -
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2
por: Schuyer, M, et al.
Publicado: (2001) -
DNA methylation in the promoter region of the p16 (CDKN2/MTS-1/INK4A) gene in human breast tumours
por: Woodcock, D M, et al.
Publicado: (1999) -
Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.
por: Schmidt, E. E., et al.
Publicado: (1997)